{"id":"standard-of-care-intravenous-antibiotics","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypersensitivity reactions (rash, anaphylaxis)"},{"rate":null,"effect":"Nephrotoxicity"},{"rate":null,"effect":"Ototoxicity"},{"rate":null,"effect":"Phlebitis at infusion site"},{"rate":null,"effect":"Diarrhea/Clostridioides difficile infection"},{"rate":null,"effect":"Hepatotoxicity"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This category encompasses multiple antibiotic classes (beta-lactams, aminoglycosides, fluoroquinolones, glycopeptides, etc.) that target different bacterial structures and processes. IV formulations provide high systemic concentrations for serious infections where oral bioavailability is insufficient or rapid onset is critical. The specific mechanism depends on the individual antibiotic agent used.","oneSentence":"Standard-of-care intravenous antibiotics work by inhibiting bacterial protein synthesis, cell wall formation, or nucleic acid replication to kill or stop the growth of susceptible bacteria.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:09:30.288Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Serious bacterial infections requiring intravenous therapy (e.g., sepsis, pneumonia, meningitis, endocarditis)"},{"name":"Hospital-acquired infections"},{"name":"Surgical prophylaxis"}]},"trialDetails":[{"nctId":"NCT07495150","phase":"NA","title":"Intracalvariosseous Plus Intravenous Antibiotics for Moderate-to-Severe Bacterial Meningitis","status":"NOT_YET_RECRUITING","sponsor":"yilong Wang","startDate":"2026-04-01","conditions":"Blood-Brain Barrier, Bacterial Meningitis","enrollment":86},{"nctId":"NCT07184866","phase":"NA","title":"Vitamin C for Acute Kidney Injury in ACLF With Septic Shock: A Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2026-04","conditions":"Acute-on-Chronic Liver Failure (ACLF)","enrollment":110},{"nctId":"NCT06748144","phase":"PHASE2, PHASE3","title":"IO Vancomycin Spine","status":"NOT_YET_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-05","conditions":"Lumbar Fusion Surgery","enrollment":30},{"nctId":"NCT07492888","phase":"PHASE2","title":"Nogapendekin Alfa-Inbakicept and iNKT Cells for Critically Ill Adults With Severe Community-Acquired Pneumonia (With or Without Sepsis/ARDS)","status":"NOT_YET_RECRUITING","sponsor":"ImmunityBio, Inc.","startDate":"2026-04-15","conditions":"Acute Respiratory Distress Syndrome, Severe Community-Acquired Pneum, Sepsis","enrollment":20},{"nctId":"NCT07489274","phase":"PHASE4","title":"Adjunctive Hyperbaric Oxygen Treatment for Patients With Necrotizing Soft-Tissue Infection (HOT-NSTI Trial). Investigator-initiated, International, Multicentre, Superiority, Randomized, Open-label, Clinical Trial.","status":"NOT_YET_RECRUITING","sponsor":"Ole Hyldegaard","startDate":"2027-04-01","conditions":"Necrotizing Soft Tissue Infection","enrollment":1480},{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT07237048","phase":"PHASE2, PHASE3","title":"Minocycline in Stroke Study at Maimonides","status":"RECRUITING","sponsor":"Joyce Chen","startDate":"2026-02-02","conditions":"Stroke, Ischemia Stroke, Hemorrhagic Strokes","enrollment":1164},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT06715306","phase":"NA","title":"Intravenous Versus Oral Treatment of the Main Acute Infections","status":"RECRUITING","sponsor":"University of Southern Denmark","startDate":"2025-01-15","conditions":"Respiratory Tract Infections, Urinary Tract Infections, Cellulitis","enrollment":4000},{"nctId":"NCT07383103","phase":"PHASE4","title":"Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock","status":"RECRUITING","sponsor":"Northern Jiangsu People's Hospital","startDate":"2026-03-02","conditions":"Septic Shock","enrollment":336},{"nctId":"NCT06494072","phase":"PHASE4","title":"Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2024-08-22","conditions":"Community Acquired Pneumonia in Children","enrollment":236},{"nctId":"NCT06086626","phase":"PHASE2","title":"A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants","status":"COMPLETED","sponsor":"Shionogi","startDate":"2024-03-14","conditions":"Gram-Negative Bacterial Infections","enrollment":30},{"nctId":"NCT07414693","phase":"PHASE4","title":"Effect of Vitamin C on Length of Hospital Stay in Children With Severe Pneumonia","status":"RECRUITING","sponsor":"Children's Hospital and Institute of Child Health, Multan","startDate":"2025-08-28","conditions":"Pneumonia Childhood, Vitamin C, Hospital Stay Time","enrollment":90},{"nctId":"NCT06954129","phase":"PHASE4","title":"A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2026-01-28","conditions":"Acute Kidney Injury","enrollment":750},{"nctId":"NCT07399717","phase":"NA","title":"Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Anabio R&D","startDate":"2026-01-26","conditions":"Pneumonia, Pneumonia in Children","enrollment":330},{"nctId":"NCT06605118","phase":"PHASE3","title":"Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial","status":"RECRUITING","sponsor":"The George Washington University Biostatistics Center","startDate":"2024-11-06","conditions":"Obstetrical Complications, Labor and Delivery Complication, Cesarean Delivery","enrollment":8000},{"nctId":"NCT05699174","phase":"PHASE3","title":"PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation","status":"RECRUITING","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2023-05-30","conditions":"Infections, Infected Wound, Nonunion of Fracture","enrollment":250},{"nctId":"NCT07369336","phase":"PHASE4","title":"Clinical Outcomes of Inhaled Amikacin in Ventilator Associated Pneumonia","status":"COMPLETED","sponsor":"Postgraduate Medical Institute, Lahore","startDate":"2024-01-05","conditions":"Ventilator Associated Pneumonia ( VAP)","enrollment":90},{"nctId":"NCT07361185","phase":"NA","title":"A Sticker Reminder Intervention to Promote IV-to-PO Fluoroquinolone Switching","status":"TERMINATED","sponsor":"Mahidol University","startDate":"2020-07-01","conditions":"Fluoroquinolone, Adult","enrollment":168},{"nctId":"NCT07209735","phase":"NA","title":"Effectiveness of the MINUTES Bundle for Initial 30-Minute Management of Undifferentiated Circulatory Shock in the Emergency Department","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-12-20","conditions":"Validation of Minute Bundle in Undifferntiated Shock","enrollment":202},{"nctId":"NCT07348471","phase":"NA","title":"Fecal Microbiota Transplantation for the Treatment of ICU Delirium","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2026-02-01","conditions":"Delirium","enrollment":60},{"nctId":"NCT06970262","phase":"NA","title":"FMT for Lung and Associated-organ Rescue Efficacy in Pulmonary Infection With MDROs","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2025-05-20","conditions":"Lung Infection, Microbial Colonization, Food Intolerance Syndromes","enrollment":150},{"nctId":"NCT06692452","phase":"PHASE2","title":"Tazemetostat Plus CHOP in 1L T-cell Lymphoma","status":"SUSPENDED","sponsor":"Eric Jacobsen, MD","startDate":"2024-12-24","conditions":"Lymphoma, Peripheral T Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma","enrollment":24},{"nctId":"NCT05544565","phase":"PHASE4","title":"3-day IV Antibiotic Treatment Versus 3-day IV Followed by 7-day Oral Antibiotic Treatment for AP in Children","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-03-22","conditions":"Pyelonephritis Acute","enrollment":480},{"nctId":"NCT07313605","phase":"PHASE1, PHASE2","title":"POCUS-Guided Esmolol in Septic Shock: A Pilot RCT","status":"NOT_YET_RECRUITING","sponsor":"John Basmaji","startDate":"2026-01-15","conditions":"Septic Shock","enrollment":100},{"nctId":"NCT07283068","phase":"NA","title":"IO Vancomycin Into the Medial Malleolus vs IV Administration in Revision TKA","status":"NOT_YET_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-02-15","conditions":"Revision Total Knee Arthroplasty","enrollment":40},{"nctId":"NCT07236944","phase":"PHASE4","title":"Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care","status":"RECRUITING","sponsor":"Uppsala University","startDate":"2025-12","conditions":"Febrile Urinary Tract Infection","enrollment":560},{"nctId":"NCT07261930","phase":"PHASE4","title":"Effectiveness of Tranexamic Acid in Reducing Blood Loss During Femoral Nail Surgery","status":"COMPLETED","sponsor":"Masaka Regional Referral Hospital","startDate":"2018-10-01","conditions":"Femoral Fractures, Hemorrhage, Surgical, Tranexamic Acid Use","enrollment":43},{"nctId":"NCT07212582","phase":"PHASE3","title":"Human Albumin for Resuscitation in Surgical Septic Shock: A Randomized Controlled Trial (ALBUS Study)","status":"NOT_YET_RECRUITING","sponsor":"Mahidol University","startDate":"2025-12-01","conditions":"Critical Illness, Septic Shock","enrollment":304},{"nctId":"NCT07227584","phase":"PHASE2","title":"ALL Backbone in AYAs","status":"NOT_YET_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2026-04","conditions":"Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Negative Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL)","enrollment":67},{"nctId":"NCT05137119","phase":"PHASE4","title":"Staphylococcus Aureus Network Adaptive Platform Trial","status":"RECRUITING","sponsor":"University of Melbourne","startDate":"2022-02-16","conditions":"Staphylococcus Aureus Bacteremia","enrollment":8000},{"nctId":"NCT07188207","phase":"NA","title":"Rectal Misoprostol for Reducing Blood Loss in Elective Cesarean Section","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-10-01","conditions":"Postpartum Hemorrhage","enrollment":282},{"nctId":"NCT07179003","phase":"PHASE2","title":"A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-04","conditions":"Breast Abscess","enrollment":50},{"nctId":"NCT05831774","phase":"PHASE4","title":"IO Vancomycin in TSA","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2023-06-01","conditions":"Shoulder Injuries","enrollment":33},{"nctId":"NCT06644612","phase":"NA","title":"Light vs Heavy Weighted Mesh Repair in Primary Abdominal Hernia in Terms of Surgical Site Infection","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2024-08-01","conditions":"Abdominal Hernia","enrollment":106},{"nctId":"NCT05977868","phase":"PHASE4","title":"Comparing Oral Versus Parenteral Antimicrobial Therapy","status":"TERMINATED","sponsor":"West Virginia University","startDate":"2023-08-04","conditions":"Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection","enrollment":94},{"nctId":"NCT07131306","phase":"PHASE2","title":"National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem Cell Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patient- Phase-II Trial","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2027-01","conditions":"Acute-On-Chronic Liver Failure","enrollment":100},{"nctId":"NCT07075315","phase":"PHASE3","title":"National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2028-01","conditions":"Acute-On-Chronic Liver Failure","enrollment":100},{"nctId":"NCT07122596","phase":"PHASE4","title":"EFFICACY OF PROLONGED INFUSION MEROPENEM IN CRITICALLY ILL PAEDIATRIC INTENSIVE CARE PATIENTS","status":"COMPLETED","sponsor":"Pakistan Navy Station Shifa Hospital","startDate":"2024-04-01","conditions":"Sepsis, Bacterial Infection","enrollment":150},{"nctId":"NCT06269900","phase":"PHASE3","title":"Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2024-03-26","conditions":"Hospital Acquired Pneumonia","enrollment":450},{"nctId":"NCT07107555","phase":"","title":"Necrotizing Soft Tissue Infections","status":"ENROLLING_BY_INVITATION","sponsor":"European Society for Trauma and Emergency Surgery","startDate":"2026-01-01","conditions":"Necrotizing Soft Tissue Infection, Fournier Gangrene, Sepsis","enrollment":480},{"nctId":"NCT07107477","phase":"PHASE3","title":"TAILORED Therapeutic Regime in Patients With Preterm Premature Rupture Of Membranes to Prolong Pregnancy, Improve Maternal and Neonatal Outcomes, and Reduce Antibiotic Burden","status":"RECRUITING","sponsor":"The Central and Eastern European Gynecologic Oncology Group","startDate":"2025-05-01","conditions":"Preterm Premature Rupture of Membranes (PPROM)","enrollment":138},{"nctId":"NCT03935828","phase":"PHASE2","title":"Effect of Topical Sinonasal Antibiotics","status":"WITHDRAWN","sponsor":"United States Naval Medical Center, San Diego","startDate":"2019-06","conditions":"Chronic Rhinosinusitis (Diagnosis), Antibiotic Side Effect","enrollment":""},{"nctId":"NCT06423898","phase":"PHASE4","title":"Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.","status":"RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2024-10-09","conditions":"Endocarditis, Infective","enrollment":284},{"nctId":"NCT06873633","phase":"PHASE2","title":"Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV","status":"RECRUITING","sponsor":"PENTA Foundation","startDate":"2025-07-16","conditions":"Respiratory Syncytial Virus (RSV)","enrollment":120},{"nctId":"NCT06184659","phase":"PHASE4","title":"Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis","status":"RECRUITING","sponsor":"Scandinavian Critical Care Trials Group","startDate":"2025-06-26","conditions":"Sepsis, Septic Shock","enrollment":5800},{"nctId":"NCT06640491","phase":"PHASE1, PHASE2","title":"Intraosseous (IO) Cefazolin and Vancomycin in Primary Total Knee Arthroplasty (TKA)","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2025-05-15","conditions":"Total Knee Arthroplasty","enrollment":40},{"nctId":"NCT06847126","phase":"PHASE3","title":"Empirical Intravenous Beta-Lactam Plus Metronidazole Vs Oral Cefixime Plus Metronidazole for the Treatment of Liver Abscess","status":"RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2025-02-25","conditions":"Liver Abscess","enrollment":220},{"nctId":"NCT04884490","phase":"PHASE2, PHASE3","title":"The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients","status":"COMPLETED","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2021-05-15","conditions":"COVID-19 Pneumonia","enrollment":94},{"nctId":"NCT06891599","phase":"","title":"ROTEM in Sepsis Trauma Outcome in Intensive Care","status":"RECRUITING","sponsor":"Region Stockholm","startDate":"2024-11-01","conditions":"Sepsis - to Reduce Mortality in the Intensive Care Unit, Trauma Coagulopathy","enrollment":600},{"nctId":"NCT05470517","phase":"PHASE2","title":"Antibiotic Instillation in Appendicitis","status":"COMPLETED","sponsor":"Johns Hopkins All Children's Hospital","startDate":"2023-01-05","conditions":"Complicated Appendicitis, Acute Appendicitis","enrollment":190},{"nctId":"NCT06771050","phase":"PHASE4","title":"Randomised Arthroplasty Infection Worldwide Multidomain Adaptive Platform (ROADMAP) Trial","status":"NOT_YET_RECRUITING","sponsor":"University of Newcastle, Australia","startDate":"2025-03-26","conditions":"Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee, Large Joint Prosthetic Joint Infections","enrollment":2500},{"nctId":"NCT06845137","phase":"PHASE1","title":"Impact of Tactile Kinesthetic Stimulation and Soft Tissue Manipulation on Cortisol in Preterm","status":"NOT_YET_RECRUITING","sponsor":"faizan kashoo, PT","startDate":"2025-03-20","conditions":"Neonatal Disorder","enrollment":60},{"nctId":"NCT06384651","phase":"PHASE4","title":"Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2024-12-03","conditions":"Infections, Ankle Arthritis","enrollment":40},{"nctId":"NCT05849090","phase":"EARLY_PHASE1","title":"Vancomycin and Tobramycin Powder Use in Acute Open Fractures","status":"COMPLETED","sponsor":"University of Utah","startDate":"2023-03-27","conditions":"Infections","enrollment":10},{"nctId":"NCT06015165","phase":"NA","title":"Outcomes for Anesthesiologist-Led Care of Analgesic Protocol in Anorectal Surgery","status":"RECRUITING","sponsor":"China-Japan Friendship Hospital","startDate":"2024-09-10","conditions":"Postoperative Pain","enrollment":216},{"nctId":"NCT03355053","phase":"PHASE2","title":"Investigation of Sleep in the Intensive Care Unit","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2018-05-29","conditions":"Delirium, Sleep","enrollment":522},{"nctId":"NCT06622343","phase":"","title":"Predictive Modeling of Necrotizing Skin Infections in Snakebite Patients","status":"COMPLETED","sponsor":"Guangzhou Institute of Respiratory Disease","startDate":"2020-01-01","conditions":"Necrotizing Skin Infections, Snakebite Envenomation","enrollment":99},{"nctId":"NCT05548283","phase":"PHASE4","title":"Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study","status":"RECRUITING","sponsor":"Chris Goss","startDate":"2023-04-23","conditions":"Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation","enrollment":730},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04544306","phase":"NA","title":"Partial Oral Antimicrobials to Treat Infective Endocarditis in People Who Inject Drugs","status":"UNKNOWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2021-06-01","conditions":"Infective Endocarditis","enrollment":50},{"nctId":"NCT04381936","phase":"PHASE3","title":"Randomised Evaluation of COVID-19 Therapy","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2020-03-19","conditions":"Severe Acute Respiratory Syndrome","enrollment":70000},{"nctId":"NCT05663905","phase":"PHASE4","title":"Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients","status":"COMPLETED","sponsor":"National University of Malaysia","startDate":"2023-01-07","conditions":"Severe Pneumonia, Community-acquired Pneumonia, Hospital-acquired Pneumonia","enrollment":32},{"nctId":"NCT02687464","phase":"NA","title":"Appendectomy Versus Non-Operative Treatment For Acute Non-Perforated Appendicitis in Children","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2016-01-20","conditions":"Appendicitis","enrollment":978},{"nctId":"NCT05199324","phase":"PHASE4","title":"Early Oral Step-down Antibiotic Therapy for Uncomplicated Gram-negative Bacteraemia","status":"UNKNOWN","sponsor":"Tan Tock Seng Hospital","startDate":"2022-04-01","conditions":"Gram-negative Bacteraemia","enrollment":720},{"nctId":"NCT03426761","phase":"PHASE4","title":"Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections","status":"COMPLETED","sponsor":"Infectious Diseases Physicians, Inc.","startDate":"2018-01-25","conditions":"Bone Infection, Osteomyelitis, Septic Arthritis","enrollment":41},{"nctId":"NCT02389036","phase":"PHASE3","title":"Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients","status":"COMPLETED","sponsor":"The George Institute","startDate":"2017-05-01","conditions":"Critical Illness, Sepsis, Septic Shock","enrollment":20010},{"nctId":"NCT03439124","phase":"PHASE3","title":"Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia","status":"COMPLETED","sponsor":"Basilea Pharmaceutica","startDate":"2017-11-27","conditions":"Community-acquired Pneumonia (CAP), Hospital-acquired Pneumonia (HAP)","enrollment":138},{"nctId":"NCT05705843","phase":"PHASE4","title":"IO vs IV Vancomycin in Tourniquetless TKA","status":"UNKNOWN","sponsor":"The Methodist Hospital Research Institute","startDate":"2023-01-25","conditions":"Infection, Surgical Site","enrollment":40},{"nctId":"NCT05702619","phase":"","title":"Hypoxia-driven Prostate Cancer Genomics (HYPROGEN)","status":"UNKNOWN","sponsor":"The Christie NHS Foundation Trust","startDate":"2021-10-03","conditions":"Prostate Cancer, Hypoxia","enrollment":60},{"nctId":"NCT05393505","phase":"PHASE4","title":"Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against Infection","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2022-10-24","conditions":"Neutropenic Fever","enrollment":344},{"nctId":"NCT04891172","phase":"PHASE2, PHASE3","title":"Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients","status":"UNKNOWN","sponsor":"Dow University of Health Sciences","startDate":"2021-08-01","conditions":"Covid19","enrollment":310},{"nctId":"NCT03542461","phase":"PHASE3","title":"Early Switch Maintenance vs Delayed Second-line Nivolumab in Advanced Stage Squamous Non-small Cell Lung Cancer (NSCLC) Patients (EDEN Trial)","status":"UNKNOWN","sponsor":"Gruppo Oncologico Italiano di Ricerca Clinica","startDate":"2017-09-25","conditions":"Squamous Non-small Cell Lung Cancer","enrollment":125},{"nctId":"NCT04382651","phase":"PHASE2","title":"Study of Efficacy and Safety of MAS825 in Patients With COVID-19","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2020-06-11","conditions":"COVID-19 Pneumonia, Impaired Respiratory Function","enrollment":140},{"nctId":"NCT04335305","phase":"PHASE2","title":"Checkpoint Blockade in COVID-19 Pandemic","status":"TERMINATED","sponsor":"MedSIR","startDate":"2020-04-09","conditions":"COVID-19, Pneumonia, Viral","enrollment":12},{"nctId":"NCT05367479","phase":"PHASE1","title":"Antibiotics, Gastric Bypass, and the Microbiome","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2018-07-18","conditions":"Obesity, Morbid, Hypertension, Bariatric Surgery Candidate","enrollment":23},{"nctId":"NCT03148756","phase":"PHASE2","title":"Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis","status":"TERMINATED","sponsor":"AbbVie","startDate":"2017-05-12","conditions":"Endocarditis, Bacteremia","enrollment":2},{"nctId":"NCT03959345","phase":"PHASE4","title":"Efficacy of Cloxacillin and Fosfomycin Combination Versus Cloxacillin Monotherapy in Patients With MSSA Bacteremia","status":"TERMINATED","sponsor":"Miquel Pujol","startDate":"2019-05-31","conditions":"Methicillin Susceptible Staphylococcus Aureus Septicemia","enrollment":215},{"nctId":"NCT02991937","phase":"PHASE4","title":"Comparison of Medical and Surgical Treatment of Uncomplicated Acute Appendicitis in Children","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2016-12","conditions":"Appendicitis","enrollment":39},{"nctId":"NCT03593252","phase":"NA","title":"Bowel Preparation in Elective Pediatric Colorectal Surgery","status":"UNKNOWN","sponsor":"McMaster University","startDate":"2022-01-01","conditions":"Colostomy, Hirschsprung Disease - Pull Through, Necrotizing Enterocolitis","enrollment":81},{"nctId":"NCT03020407","phase":"NA","title":"The Randomized Controlled Trial of Inferior Vena Cava Ultrasound-guided Fluid Management in Septic Shock Resuscitation","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2017-01-18","conditions":"Septic Shock","enrollment":211},{"nctId":"NCT03066453","phase":"PHASE3","title":"Evaluation of Short Antibiotic Combination Courses Followed by Aerosols in Cystic Fibrosis","status":"TERMINATED","sponsor":"University Hospital, Lille","startDate":"2017-06-13","conditions":"Cystic Fibrosis","enrollment":23},{"nctId":"NCT05014373","phase":"PHASE3","title":"Philippine Trial to Determine Efficacy and Safety of Favipiravir for COVID-19","status":"UNKNOWN","sponsor":"University of the Philippines","startDate":"2020-10-12","conditions":"Covid19","enrollment":144},{"nctId":"NCT04953247","phase":"","title":"Use of Compromised Lung Volume in Monitoring Usage of Steroid Therapy on Severe COVID-19","status":"COMPLETED","sponsor":"Guowei Tu","startDate":"2020-02-07","conditions":"COVID-19 Pneumonia, Quantitative Computed Tomography","enrollment":72},{"nctId":"NCT04839653","phase":"NA","title":"Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria","status":"UNKNOWN","sponsor":"MEDSI Clinical Hospital 1, ICU","startDate":"2021-05-01","conditions":"Pneumonia, Ventilator-Associated, Pneumonia, Bloodstream Infection","enrollment":60},{"nctId":"NCT04907812","phase":"PHASE4","title":"The Role of Tranexamic Acid in Reducing Post Operative Hand Edema After Hand and Wrist Surgery","status":"UNKNOWN","sponsor":"Ruby Grewal","startDate":"2021-06-01","conditions":"Hand Injuries and Disorders, Distal Radius Fracture, Dupuytren Contracture","enrollment":50},{"nctId":"NCT04871633","phase":"NA","title":"Effectiveness of Remedesvir in COVID-19 Patients Presenting at Mayo Hospital Lahore","status":"COMPLETED","sponsor":"King Edward Medical University","startDate":"2020-08-01","conditions":"COVID-19","enrollment":66},{"nctId":"NCT04521309","phase":"PHASE1, PHASE2","title":"SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients","status":"COMPLETED","sponsor":"Dow University of Health Sciences","startDate":"2020-06-19","conditions":"COVID-19","enrollment":50},{"nctId":"NCT04788121","phase":"PHASE3","title":"Efficacy of Tranexamic Acid in Upper Gastrointestinal Bleeding","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2020-11-01","conditions":"Gastro Intestinal Bleeding","enrollment":160},{"nctId":"NCT03794765","phase":"PHASE2","title":"Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2019-04-01","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases, Acute Severe Colitis","enrollment":50},{"nctId":"NCT04470531","phase":"PHASE2","title":"Role of Co-trimoxazole in Severe COVID-19 Patients","status":"UNKNOWN","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2020-07-12","conditions":"Covid19, Severe COVID-19 Patients","enrollment":94},{"nctId":"NCT02961764","phase":"PHASE4","title":"Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)","status":"COMPLETED","sponsor":"Allergan","startDate":"2016-11-29","conditions":"Acute Bacterial Skin and Skin Structure Infections","enrollment":313},{"nctId":"NCT04306705","phase":"","title":"Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2020-02-20","conditions":"Covid-19, SARS, Cytokine Storm","enrollment":120},{"nctId":"NCT02692638","phase":"PHASE2","title":"Trial Comparing Early Laparoscopic Enterolysis Versus Nonoperative Management for High-grade SBO","status":"TERMINATED","sponsor":"Yale University","startDate":"2016-02-02","conditions":"Small Bowel Obstruction","enrollment":3},{"nctId":"NCT03162250","phase":"PHASE1","title":"Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2017-07-13","conditions":"Bacteremia","enrollment":27},{"nctId":"NCT03233438","phase":"PHASE4","title":"Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)","status":"COMPLETED","sponsor":"Allergan","startDate":"2017-07-24","conditions":"Bacterial Infections, Acute Bacterial Skin and Skin Structure Infection","enrollment":91},{"nctId":"NCT04141787","phase":"PHASE4","title":"Ceftriaxone as Home IV for Staph Infections","status":"UNKNOWN","sponsor":"Vancouver Island Health Authority","startDate":"2019-07-11","conditions":"Staphylococcal Infections, Osteomyelitis, CNS Infection","enrollment":310},{"nctId":"NCT02266706","phase":"PHASE1","title":"Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)","status":"COMPLETED","sponsor":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","startDate":"2014-09-17","conditions":"Proven or Suspected Gram-negative Bacterial Infection, Peri-operative Prophylaxis","enrollment":43},{"nctId":"NCT02098993","phase":"PHASE2","title":"Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome","status":"TERMINATED","sponsor":"Craig Seaman","startDate":"2014-05","conditions":"Acute Chest Syndrome, Sickle Cell Disease","enrollment":7},{"nctId":"NCT04000711","phase":"NA","title":"Safety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile Neutropenia","status":"COMPLETED","sponsor":"Hospital Infantil de Mexico Federico Gomez","startDate":"2015-07-01","conditions":"Chemotherapy-Induced Febrile Neutropenia","enrollment":117}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Standard-of-Care Intravenous Antibiotics","genericName":"Standard-of-Care Intravenous Antibiotics","companyName":"Postgraduate Medical Institute, Lahore","companyId":"postgraduate-medical-institute-lahore","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Standard-of-care intravenous antibiotics work by inhibiting bacterial protein synthesis, cell wall formation, or nucleic acid replication to kill or stop the growth of susceptible bacteria. Used for Serious bacterial infections requiring intravenous therapy (e.g., sepsis, pneumonia, meningitis, endocarditis), Hospital-acquired infections, Surgical prophylaxis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}